Clinical trial
The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell…
NCT00440583 · Mahidol University, Other · Completed
Key facts
| NCT number | NCT00440583 |
|---|---|
| Title | The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP |
| Official title | Yt90 Zevalin & Combination Chemotherapy in Treating Patients With Stage II,Stage III,or Stage IV Diffuse Large B-cell Lymphoma |
| Lead sponsor | Mahidol University, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diffuse Large B-cell Lymphoma |
| Intervention type | Drug |
| Interventions | chemotherapy followed by Zevalin |
| Enrollment | 15 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2011 |
| Completion | May 1, 2012 |
| First posted | Feb 27, 2007 |
| Last update posted | Jan 30, 2015 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: